Curia Completes Aseptic Suites Upgrade In Valladolid

KUALA LUMPUR, May 20 (Bernama) -- Curia Global Inc (Curia), a global research, development and manufacturing organisation, has completed upgrades to its two aseptic suites in Valladolid as part of a US$4 million investment aligned with the European Union’s Good Manufacturing Practice (GMP) Annex 1 standards. (US$1=RM3.97)

Curia said the project’s central feature was the transition to a fully closed system aimed at strengthening process and product integrity while minimising microbiological risks throughout production stages.

The upgrades also included the installation of advanced isolators and improvements to HVAC systems, pharmaceutical utilities, automation, and sterilisation-in-place processes.

Curia Chief Executive Officer, Philip Macnabb said the investment reflects the company’s commitment to supporting customers with high-quality sterile manufacturing capabilities.

“These facility enhancements position us as a stronger partner when it comes to producing increasingly complex sterile products while maintaining the high standards of quality assurance that regulators and customers expect,” he said in a statement.

According to Curia, the enhanced aseptic capabilities will provide greater flexibility, reliability, and speed in sterile manufacturing operations.

The company added that the Valladolid facility is now positioned to deliver consistent, large-scale supply through advanced closed processing systems and strengthened contamination controls.

-- BERNAMA